GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Cangene Corporation (FRA:YGE) » Definitions » Market Cap

Cangene (FRA:YGE) Market Cap : €152.18 Mil (As of May. 16, 2024)


View and export this data going back to . Start your Free Trial

What is Cangene Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Cangene's share price for the quarter that ended in Oct. 2013 was €1.842. Cangene's Shares Outstanding (EOP) for the quarter that ended in Oct. 2013 was 66.75 Mil. Therefore, Cangene's market cap for the quarter that ended in Oct. 2013 was €122.95 Mil.

Cangene's quarterly market cap declined from Apr. 2013 (€154.99 Mil) to Jul. 2013 (€119.74 Mil) but then increased from Jul. 2013 (€119.74 Mil) to Oct. 2013 (€122.95 Mil).

Cangene's annual market cap increased from Jul. 2011 (€0.00 Mil) to Jul. 2012 (€81.16 Mil) and increased from Jul. 2012 (€81.16 Mil) to Jul. 2013 (€119.74 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Cangene's Enterprise Value for Today is €152.18 Mil.


Cangene Market Cap Historical Data

The historical data trend for Cangene's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cangene Market Cap Chart

Cangene Annual Data
Trend Jul04 Jul05 Jul06 Jul07 Jul08 Jul09 Jul10 Jul11 Jul12 Jul13
Market Cap
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - 81.16 119.74

Cangene Quarterly Data
Jan09 Apr09 Jul09 Oct09 Jan10 Apr10 Jul10 Oct10 Jan11 Apr11 Jul11 Oct11 Jan12 Apr12 Jul12 Oct12 Jan13 Apr13 Jul13 Oct13
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - 154.99 119.74 122.95

Competitive Comparison of Cangene's Market Cap

For the Biotechnology subindustry, Cangene's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Cangene's Market Cap Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Cangene's Market Cap distribution charts can be found below:

* The bar in red indicates where Cangene's Market Cap falls into.



Cangene Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Cangene's Market Cap for the fiscal year that ended in Jul. 2013 is calculated as

Market Cap (A: Jul. 2013 )=Share Price (A: Jul. 2013 )*Shares Outstanding (EOP) (A: Jul. 2013 )
=€1.794*66.7469
=€119.74

Cangene's Market Cap for the quarter that ended in Oct. 2013 is calculated as

Market Cap (Q: Oct. 2013 )=Share Price (Q: Oct. 2013 )*Shares Outstanding (EOP) (Q: Oct. 2013 )
=€1.842*66.7469
=€122.95

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Cangene  (FRA:YGE) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Cangene Market Cap Related Terms

Thank you for viewing the detailed overview of Cangene's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Cangene (FRA:YGE) Business Description

Traded in Other Exchanges
N/A
Address
Cangene Corporation is a fully integrated developer and manufacturer of immune therapeutics, primarily targeting infectious disease, hematology, transplantation and biodefense applications. The company manages its business and evaluate performance based on two operating segments: biopharmaceutical operations and contract services. Revenues are generated from product sales, and contract manufacturing and contract-R&D services.

Cangene (FRA:YGE) Headlines

No Headlines